189.00

2.75% 5.06

Tenet Healthcare Corp (THC)

Overview News Price History Option Chain Financials Why THC Down? Discussions Forecast Stock Split Dividend History

Tenet Healthcare Corp stock is traded at $189.00, with a volume of 1.57M. It is up +2.75% in the last 24 hours and up +7.16% over the past month. Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Previous Close:

$183.94

Open:

$184.39

24h Volume:

1.57M

Relative Volume:

1.12

Market Cap:

$16.28B

Revenue:

$21.46B

Net Income/Loss:

$2.65B

P/E Ratio:

9.8278

EPS:

19.2312

Net Cash Flow:

$3.35B

1W Performance:

+9.52%

1M Performance:

+7.16%

6M Performance:

-5.78%

1Y Performance:

+9.53%

1-Day Range:

$181.40

$189.00

1-Week Range:

$171.75

$189.00

52-Week Range:

$146.60

$247.21

Tenet Healthcare Corp Stock (THC) Company Profile

Name

Tenet Healthcare Corp

Sector

Healthcare (1096)

Industry

Medical Care Facilities (52)

Phone

469-893-2200

Address

14201 DALLAS PARKWAY, DALLAS, TX

Employee

99,000

Twitter

@tenethealth

Next Earnings Date

2026-07-24

Latest SEC Filings

THC's Discussions on Twitter

Compare THC vs HCA, DVA, FMS, EHC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
THC Tenet Healthcare Corp	189.00	16.28B	21.46B	2.65B	3.35B	19.23
HCA Hca Healthcare Inc	391.68	86.89B	76.39B	7.81B	7.93B	29.08
DVA Davita Inc	217.04	13.93B	13.84B	1.10B	1.49B	10.42
FMS Fresenius Medical Care Ag Adr	23.24	12.48B	22.44B	1.35B	2.03B	1.9002
EHC Encompass Health Corp	101.33	10.05B	6.07B	793.80M	464.40M	5.9914

Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-25	Resumed	Goldman	Buy
Jul-28-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-29-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-26-25	Initiated	Morgan Stanley	Overweight
Feb-26-25	Initiated	TD Cowen	Buy
Dec-17-24	Resumed	JP Morgan	Overweight
Dec-16-24	Downgrade	Goldman	Buy → Neutral
Nov-25-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Nov-22-24	Downgrade	Raymond James	Strong Buy → Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-27-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Mar-06-24	Initiated	Barclays	Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Apr-19-23	Initiated	JP Morgan	Overweight
Jun-17-22	Initiated	Loop Capital	Buy
Mar-29-22	Initiated	Wells Fargo	Overweight
Feb-10-22	Upgrade	UBS	Neutral → Buy
Feb-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Feb-09-22	Upgrade	Truist	Hold → Buy
Jan-20-22	Upgrade	Raymond James	Outperform → Strong Buy
Jan-10-22	Resumed	Citigroup	Buy
Sep-27-21	Initiated	SVB Leerink	Mkt Perform
Sep-24-21	Initiated	UBS	Neutral
Aug-12-21	Upgrade	Barclays	Equal Weight → Overweight
Jul-23-21	Resumed	Citigroup	Buy
Jul-09-21	Initiated	Seaport Global Securities	Buy
May-03-21	Resumed	Goldman	Buy
Jan-08-21	Upgrade	Jefferies	Hold → Buy
Jan-05-21	Upgrade	BofA Securities	Neutral → Buy
Dec-15-20	Upgrade	Deutsche Bank	Hold → Buy
Sep-21-20	Downgrade	JP Morgan	Neutral → Underweight
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Feb-26-20	Upgrade	JP Morgan	Underweight → Neutral
Dec-09-19	Upgrade	UBS	Neutral → Buy
Nov-06-19	Upgrade	Credit Suisse	Neutral → Outperform
Aug-14-19	Resumed	Goldman	Neutral
Feb-26-19	Reiterated	BofA/Merrill	Neutral
Jan-14-19	Initiated	Stephens	Equal-Weight
Jan-03-19	Initiated	Deutsche Bank	Hold
Dec-17-18	Downgrade	Robert W. Baird	Outperform → Neutral
Nov-16-18	Initiated	UBS	Neutral
Jun-29-18	Downgrade	Jefferies	Buy → Hold
Mar-23-18	Resumed	Mizuho	Buy
Jan-30-18	Resumed	Wells Fargo	Market Perform
Jan-03-18	Initiated	Goldman	Neutral
Dec-20-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-19-17	Reiterated	Mizuho	Neutral
Dec-14-17	Downgrade	JP Morgan	Neutral → Underweight
Dec-12-17	Upgrade	Citigroup	Neutral → Buy

View All

Tenet Healthcare Corp Stock (THC) Latest News

Jun 26, 2026

HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026

Jun 25, 2026

The ambulatory surgical centers from Tenet Healthcare Corpa quiet backbone of US elective care - Ad-hoc-news.de

Jun 25, 2026

Tenet Healthcare Corp updates investor guidance, shares hold steady on NYSE - Ad-hoc-news.de

Jun 25, 2026

THC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Why Could June Be a Key Month for (NYSE:THC) Investors? - Kalkine Media

Jun 25, 2026

Jun 23, 2026

Tenet Healthcare (THC) Ascends While Market Falls: Some Facts to Note - Yahoo Finance Singapore

Jun 23, 2026

HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 23, 2026

Tenet Healthcare clears short-term resistance, shares stay supported by bullish analyst consensus - Ad-hoc-news.de

Jun 23, 2026

Jun 22, 2026

A Look at Tenet Healthcare Corp (THC) After 3.6% Gain -- GF Value $164.51 vs Price $178.75 - GuruFocus

Jun 22, 2026

Providence stays in-house for new Memorial campus CEO after search - El Paso Times

Jun 22, 2026

THC Maintained by TD Cowen -- Price Target Lowered to $233 - GuruFocus

Jun 22, 2026

Tenet to release Q2 2026 results July 24, call at 10:30 a.m. CT - Stock Titan

Jun 22, 2026

Jun 19, 2026

Tenet Healthcare StockWeekly review and sector check on hospital operators - Ad-hoc-news.de

Jun 19, 2026

Jun 18, 2026

Why Tenet’s My Health Rec quietly matters for everyday patients - AD HOC NEWS

Jun 18, 2026